Middle East and Africa Opioids
Market Report
2024
Delivery Includes:- Market Timeline 2019 till 2031, Market Size, Revenue/Volume Share, Forecast and CAGR, Competitor Analysis, Regional Analysis, Country Analysis, Segment Analysis, Market Trends, Drivers, Opportunities, Restraints, ESG Analysis, Porters Analysis, PESTEL Analysis, Market Attractiveness, Patent Analysis, Technological Trend, SWOT Analysis, COVID-19 Analysis, Consumer Behavior Analysis, etc.
The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Middle East and Africa Opioids Market Report 2023.
According to Cognitive Market Research, the Middle East and Africa Opioids Market Size will be USD XX Billion in 2023 and is set to achieve a market size of USD XX Billion by the end of 2031 growing at a CAGR of XX% from 2024 to 2031.
Base Year | 2023 |
Historical Data Time Period | 2019-2023 |
Forecast Period | 2024-2031 |
Market Split by Product |
|
Market Split by Application |
|
Market Split by Route of Administration |
|
Market Split by Drug Class |
|
Market Split by End User |
|
Market Split by Distribution Channel |
|
List of Competitors |
|
Country Analysis | Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA | Key Qualitative Information Covered |
|
Report scope is customizable as we have a huge database of Middle East and Africa Opioids industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Middle East and Africa Opioids Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
The Middle East and Africa opioids market is anticipated to grow significantly as a result of various factors, including the increasing prevalence of chronic pain, the growing geriatric population, and the rising number of diseases such as arthritis and cancer. The United Arab Emirates (UAE) has one of the fastest-growing economies in the world, which has increased in noncommunicable diseases such as cancer. Despite screening and early detection efforts that appear to be far from the goal coverage of the intended population, the number of reported cases and deaths has been rising in the UAE over the years. The UAE's cancer management plan is being developed by WHO and EMRO guidelines, with specific aims and targets in mind. Opioid access varies widely in regions related to additional factors, such as economic stability. For example, four countries that reported the lowest consumption of morphine in the world were also the poorest in the ME: Iraq, Pakistan, Sudan, and Yemen. The availability of opioids is merely one aspect of the problem whereas there are other access constraints, such as prescription restrictions, further exacerbate the situation in the ME. For instance, morphine prescriptions are only allowed in certain nations for a maximum of seven days, whereas in others, the supply is limited to five days. For Instance, In 2010, the Middle Eastern Cancer Consortium invited the Oncology Nursing Society (ONS) to a course on spirituality's influence on pain and suffering. The course led to action plans and collaborations, including a palliative care course in Oman. Since then, ONS has conducted courses in palliative care and leadership/research, focusing on pain assessment and management in cancer and palliative care.
(Source-https://www.ons.org/onf/44/4/pain-management-middle-east-building-capacity-global-partners)
Read a Detailed Qualitative analysis of the above report by requesting the free sample pages from Request for your Free Sample PDF/Online Access.
To meet the increasing demands of consumers the industry players are now investing and giving more attention to their research and development of Opioids so that they sustain and survive in the competition. ensuring a competitive edge. Robust distribution networks and adherence to quality standards amplify market presence, fostering an environment where agility and innovation define industry leaders.
Top Companies Market Share in Middle East and Africa Opioids Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
The published report edition delivers Middle East and Africa Market size analysis from 2019 till the forecast period of 2031. We have included analysis of top performing countries such as (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA) and their Market segmentation by Product, Application, Route of Administration, Drug Class, End User, Distribution Channel, etc. This will help you to understand detailed segment profile, revenue generation, growth patterns, trends, and differences among the each segments.
Middle East and Africa Opioids market Product size and share analysis, have been revealed under this section. This section offers market size, revenue share, y-o-y growth rate along with market attractiveness for each type. This will help you to understand which type held largest revenue share along with its compound annual growth rate (CAGR) of Middle East and Africa Opioids Market.
With the help of type segment analysis, companies can understand which type has potential to invest along with its driving factors, current trends and other key factors. The timeline covered in the published North America Report edition is 2019 to 2031.
Note: The above Chart is for representative purposes and does not depict actual sales & statistics. You can request a free sample or purchase the full report access today!
The Pain Relief segment accounts for the largest market share and is expected to rise over the period it is because of the extensive requirement for efficient pain mitigation strategies. Opioids stand out as potent analgesics, delivering swift and substantial pain alleviation, and are indispensable for individuals grappling with severe or persistent pain issues. For Instance, The National Library of Medicine (2020) estimates that around 310.0 million operations are carried out annually worldwide, with 20.0 million and 40.0 to 50.0 million of those procedures occurring in Europe and the United States, respectively. Consequently, a rise in surgical procedures raises the need for medications to control pain following surgery.
(Source-https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388795/)
The Anesthesia is anticipated to grow at the fastest CAGR during the forecast period. Opioids are commonly used by anesthesiologists to induce and maintain Anesthesia, manage intraoperative pain, and provide post-operative pain relief. Intravenous opioids are commonly used to provide analgesia and supplement sedation during general Anesthesia. Additionally, the precision and efficacy of opioids in controlling pain during Anesthesia make them a preferred choice, reinforcing their substantial presence in the Anesthesia sector of the opioids market.
Note: The above Chart is for representative purposes and does not depict actual sales & statistics. You can request a free sample or purchase the full report access today!
The hospital pharmacies segment accounts for the largest market share and is expected to rise over the period as these settings are the first encounters with opioid prescriptions for patients, especially after surgeries or for acute pain management. The competitive environment is projected to get more intense as more significant pharmaceutical companies enter the oncology market, which is one of the most lucrative areas of the sales segment in hospital pharmacies. The retail pharmacies segment is anticipated to grow at the fastest CAGR during the forecast period due to its accessibility and widespread distribution network. It serves as the most accessible point for patients to fill opioid prescriptions for chronic pain management. Patients receive prescriptions from healthcare providers and fill them conveniently at these pharmacies. It offers widespread availability, convenience, and, in some regions, counseling services to ensure safe use, boosting the opioid market revenue.
The Current Published report Editon on the website includes the following list of countries analysis whereas in case you looking to access any other country or states level data under Middle East and Africa then please revert us to access the exclusive Middle East and Africa Opioids industry report Edition.
The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!
The base years considered for all the estimations by analyzing trends and growth rate will help you gain an in-depth understanding of the conclusions provided in this report. This report also includes figures, graphs, pie charts, tables and bar graphs that explain the data analysis based on current trends at the country level as well as key regions. This research report also focuses on assessing factors such as profit, product price, capacity, production, supply demand market growth rate along with others to create a clear picture on the future prospects of this market.Senior Research Associate at Cognitive Market Research
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.
Bio :Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare indust...Read More
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Middle East and Africa Opioids Market is witnessing significant growth in the near future.
In 2023, the Codeine segment accounted for noticeable share of Middle East and Africa Opioids Market and is projected to experience significant growth in the near future.
The Pain Management segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies Purdue Pharma L.P , Johnson & Johnson Services Inc and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the market.
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Table of Content differs accordign to the user License selction. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section's Or chapter's from the report. Specific section's of report can be ordered at a discounted price. If applicable; On Request Volume Data will also be provided (at an Additional Cost).
Product | Codeine, Methadone, Morphine, Oxycodone, Fentanyl, Hydrocodone, Others |
Application | Pain Management, Diarrhea Treatment, Cough Treatment, Deaddiction, Anesthesia |
Route of Administration | Oral, Injectable, Transdermal Patch, Others |
Drug Class | Immediate-Release/Short-Acting Opioids, Extended-Release /Long-Acting Opioids |
End User | Hospitals, Homecare, Speciality Centre, Others |
Distribution Channel | Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others |
List of Competitors | Purdue Pharma L.P, Sanofi, Johnson & Johnson Services Inc, AbbVie Inc., Sun Pharmaceutical Industries Ltd, Pfizer Inc., Bayer AG, Mallinckrodt Pharmaceuticals, GlaxoSmithKline plc, Aurobindo Pharma, Fresenius Kabi, Amneal Pharmaceuticals, Endo International plc., Trevena Inc., Hikma Pharmaceuticals, Rusan Pharma Ltd, Lupin Limited, Abbott Laboratories, Novartis AG, Assertio Therapeutics Inc.+ |
Chapter 1 Middle East and Africa Market Analysis
Competitor's Market Share and Revenue (Subject to Data Availability for Private Players)
Chapter 2 Competitor Analysis (Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Chapter 3 Qualitative Analysis (Subject to Data Availability)
Segmentation Product Analysis 2019 -2031, will provide market size split by Product. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 4 Market Split by Product Analysis 2019 -2031
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 5 Market Split by Application Analysis 2019 -2031
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 6 Market Split by Route of Administration Analysis 2019 -2031
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 7 Market Split by Drug Class Analysis 2019 -2031
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 8 Market Split by End User Analysis 2019 -2031
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 9 Market Split by Distribution Channel Analysis 2019 -2031
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Middle East and Africa Opioids market
Chapter 10 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Why Codeine have a significant impact on Middle East and Africa Opioids market? |
What are the key factors affecting the Codeine and Methadone of Middle East and Africa Opioids Market? |
What is the CAGR/Growth Rate of Pain Management during the forecast period? |
By type, which segment accounted for largest share of the Middle East and Africa Opioids Market? |
Which region is expected to dominate the Middle East and Africa Opioids Market within the forecast period? |
Segmentation Level Customization |
|
Global level Data Customization |
|
Region level Data Customization |
|
Country level Data Customization |
|
Company Level |
|
Additional Data Analysis |
|
Additional Qualitative Data |
|
Additional Quantitative Data |
|
Service Level Customization |
|
Report Format Alteration |
|
Published Report Editions
are Just a Tip of an Iceberg
Access the Complete Database of
Middle East and Africa Opioids Market
Request Sample